Paris Aids conference cites modest progress with trial vaccine

By Incorrect Author 21 October 2009

At a major Aids vaccine conference in Paris, researchers have looked closely at recent vaccine trials in Thailand. The trials received serious attention because they apparently showed a two-vaccine combination that provided about a 31% protection rate for humans against HIV. Shortly after that promising report, however, further studies said the results might not be as promising as first thought. At this latest conference, all data has been set out and it is clear that the combo really does provide a modest effect, researchers said. Better than garlic, African potatoes, beetroot and olive oil, anyway.


While we have your attention...

An increasingly rare commodity, quality independent journalism costs money - though not nearly as much as its absence.

Every article, every day, is our contribution to Defending Truth in South Africa. If you would like to join us on this mission, you could do much worse than support Daily Maverick's quest by becoming a Maverick Insider.

Click here to become a Maverick Insider and get a closer look at the Truth.


SARS & Gartner – global advisory giant’s mysterious deal with Moyane’s friend follows a pattern of tender corruption

By Pauli Van Wyk

"We spend the first year of a child's life teaching it to walk and talk and the rest of its life to shut up and sit down. There's something wrong there." ~ Neil deGrasse Tyson